We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Cleveland Clinic Revives Heart-Disease Test Patent Row

Law360, New York (February 22, 2017, 6:38 PM EST) -- The Cleveland Clinic Foundation on Tuesday continued its push to block True Health Diagnostics LLC from using a test for cardiovascular disease that the foundation discovered, claiming in Virginia federal court that True Health infringed one of its patents.

The complaint alleges that True Health is infringing U.S. Patent No. 9,575,065 — which is owned by the foundation and licensed exclusively to co-plaintiff Cleveland HeartLab Inc. — by using myeloperoxidase testing, which assesses cardiovascular disease risk by analyzing blood vessel inflammation.

The suit comes almost exactly...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.